News
Uptake of Leqembi for Alzheimer’s may be slow
Full FDA approval of Eisai and Biogen’s Alzheimer’s disease therapy Leqembi may have unlocked the door to a broader rollout of the drug and potentially blockbuster sales,
Monday 16 February 2026
